Lite Strategy, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Lite Strategy, Inc. (LITS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 4.50% for the 12-month period ending 2024-06-30, per its 10-K filed 2025-09-26.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-09-26
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2023-09-30 was 4.60%, a 64.29% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2022-09-30 was 2.80%, a 154.55% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2021-09-30 was 1.10%, a 175.00% increase year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-09-30 was 0.40%, a 77.78% decline year-over-year.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 4.50%, a 40.63% increase from fiscal 2023.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 3.20%, a 146.15% increase from fiscal 2022.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 1.30%, a 160.00% increase from fiscal 2021.
- Lite Strategy, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.50%, a 70.59% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2024-06-30 | 4.50% 10-K · filed 2025-09-26 | |||
| 2024-03-31 | 4.50% 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | 4.50% 10-Q · filed 2025-02-12 | |||
| 2023-09-30 | 4.60% 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 3.20% 10-K · filed 2024-09-19 | |||
| 2023-03-31 | 2.90% 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | 2.90% 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | 2.80% 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | 1.30% 10-K · filed 2023-09-26 | |||
| 2022-03-31 | 1.20% 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | 1.10% 10-Q · filed 2023-02-09 | |||
| 2021-09-30 | 1.10% 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 0.50% 10-K · filed 2022-09-08 | |||
| 2021-03-31 | 0.50% 10-Q · filed 2022-05-23 | |||
| 2020-12-31 | 0.40% 10-Q/A · filed 2022-05-23 | |||
| 2020-09-30 | 0.40% 10-Q/A · filed 2022-05-23 | |||
| 2020-06-30 | 1.70% 10-K · filed 2022-09-08 | |||
| 2020-03-31 | 1.80% 10-Q · filed 2021-05-06 | |||
| 2019-12-31 | 1.80% 10-Q · filed 2021-02-04 | |||
| 2019-09-30 | 1.80% 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | 2.70% 10-K/A · filed 2022-05-23 | |||
| 2019-03-31 | 2.80% 10-Q · filed 2020-05-07 | |||
| 2018-12-31 | 2.80% 10-Q · filed 2020-02-06 | |||
| 2018-09-30 | 2.80% 10-Q · filed 2019-11-07 | |||
| 2018-06-30 | 2.30% 10-K · filed 2020-09-09 | |||
| 2018-03-31 | 2.10% 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | 2.10% 10-Q · filed 2019-02-07 | |||
| 2017-09-30 | 2.10% 10-Q · filed 2018-11-08 | |||
| 2017-06-30 | 1.30% 10-K · filed 2019-08-28 | |||
| 2017-03-31 | 1.20% 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | 1.20% 10-Q · filed 2018-02-08 | |||
| 2016-09-30 | 1.20% 10-Q · filed 2017-11-08 | |||
| 2016-06-30 | 1.70% 10-K · filed 2018-08-30 | |||
| 2016-03-31 | 1.70% 10-Q · filed 2017-05-04 | |||
| 2015-12-31 | 1.80% 10-Q · filed 2017-02-08 | |||
| 2015-09-30 | 1.80% 10-Q · filed 2016-11-09 | |||
| 2015-06-30 | 1.60% 10-K · filed 2017-09-05 | |||
| 2015-03-31 | 1.60% 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | 1.70% 10-Q · filed 2016-02-05 | |||
| 2014-09-30 | 1.70% 10-Q · filed 2015-11-06 | |||
| 2014-06-30 | 1.50% 10-K · filed 2016-09-06 | |||
| 2014-03-31 | 1.40% 10-Q · filed 2015-05-07 | |||
| 2013-12-31 | 1.40% 10-Q · filed 2015-02-06 | |||
| 2013-09-30 | 1.40% 10-Q · filed 2014-11-06 | |||
| 2013-06-30 | 0.70% 10-K · filed 2015-09-02 | |||
| 2012-06-30 | 1.20% 10-K · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |